Abstract:Patients with SAP complicated with acute kidney injury have higher mortality than patients with SAP alone.1 CT is invaluable for the management of patients with severe acute pancreatitis. Although intravenous administration of radiographic contrast media may be helpful or essential for adequate imaging, the potential complication of contrast-induced nephropathy (CIN) is a significant concern. To the best of our knowledge, there have been no previous reported studies assessing the extent to which IV-administered contrast media for CT might affect subsequent renal function in patients with severe acute pancreatitis in an ICU setting. A retrospective analysis of a prospectively collected database was performed. The study group consisted of 107 patients who underwent Contrast-enhanced computed tomography (CECT). The demographic and clinical characteristics and medical test values from four days before to four days after scanning were logged. The inclusion criteria for SAP were defined according to the Atlanta criteria.2 Patients with SAP complicated with acute kidney injury were excluded in this study. CIN is typically defined as an increase in serum creatinine of 25 per cent over baseline, or an absolute increase of 0.5 mg/dL (44.2 mmol/L), within 48 hours of contrast administration.3 Iodinated nonionic contrast material was administered at a rate of 2.5 to 3 mL/sec for a total of 100 mL with a high-pressure autoinjector. CT enhancement was carried out in the pancreatic phase, and the scanning time was 35 seconds after injection of contrast materials. The serum level of blood urea nitrogen (BUN) was 5.250 mmol/L (±2.673 [SEM] mmol/L) on day 0, and it significantly increased to 5.289 mmol/L (±3.496 [SEM] mmol/L, P < 0.05) on the third day after CT scan. On the fourth day after CT scan, the difference was still significant when compared with the level on day 0 (5.364 ± 3.635 mmol/L vs 5.250 ± 2.673 mmol/L, P < 0.05). Average creatinine levels trended up slightly. Figure 1 summarizes the overall changes in creatinine levels from baseline to the fourth day after CT scan. However, there was no difference between the mean values of the four days before CT scan and within four days after CT scan. The value of cystatin C has a similar trend to the value of creatinine. Other clinical measurements, including alanine aminotransferase and albumin, were slightly lower than the value before CT scan. However, there was no difference either (Fig. 1). The incidence of contrast-induced nephropathy observed in this study using the previously described definitions was 8.41 per cent (9 patients in 107), and the differences between the CIN group and the nonCIN group are presented in Table 1. In patients with CIN, baseline cystatin C and hematocrit levels were significantly higher (1.466 ± 1.373 vs 3.231 ± 2.148 and 0.311 ± 0.075 vs 0.354 ± 0.10, P 4 0.016 and P 4 0.004, respectively). Hospital mortality was significantly higher in the CIN group (6.12% vs 33.33%, P < 0.05). The average Acute Physiology and Chronic Health Evaluation (APACHE II) scores of patients on admission were significantly higher in the CIN group (10.57 ± 1.969 vs 13.22 ± 3.734, P 4 0.003). Hospital duration was much shorter in the CIN group (38.29 vs 19.71, P < 0.05). Other clinical variables were no significantly different between the two groups. The logistic regression analysis of CIN indicated that significant differences existed between SAP patients with and without CIN in the following aspects: APACHE II score, baseline cystatin C, and serum hematocrit. The results correlate well with the statistical results shown in Table 1, which also suggest differences in these three parameters between the CIN and non-CIN groups. The risk of CIN from CECT in patients with SAP was associated with serum cystatin C Address correspondence and reprint requests to Weiqin Li, M.D., Department of General Surgery, Jinling Hospital, 305 Zhong Shan East Road, Nanjing, China 210002. E-mail: wsizhen@ 126.com.

Influence of contrast medium on long-term renal function and outcomes in patients with septic acute kidney injury: A propensity-matched cohort study

Is intravenous iodinated contrast medium administration really harmful in hospitalized acute kidney injury patients: a propensity score–matched study

Acute Kidney Injury in Patients with Nephrotic Syndrome Undergoing Contrast-Enhanced CT for Suspected Venous Thromboembolism: a Propensity Score-Matched Retrospective Cohort Study

Risk and harm of contrast induced nephropathy in critically ill patients

Renal Functional Recovery Confounding the Assessment of Contrast Nephropathy: Propensity Score Analysis

Cumulative Iodinated Contrast Exposure for Computed Tomography During Acute Kidney Injury and Major Adverse Kidney Events

Perioperative intravenous contrast administration and the incidence of acute kidney injury after major gastrointestinal surgery: prospective, multicentre cohort study

Protocol for a Prospective Observational Study on the Association of Variables Obtained by Contrast-Enhanced Ultrasonography and Sepsis-Associated Acute Kidney Injury

Incidence of contrast-associated acute kidney injury: a prospective cohort

Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis

Long-term effects of contrast media exposure on renal failure progression: a retrospective cohort study

Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants

Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19

Patients with Different Stages of Chronic Kidney Disease Undergoing Intravenous Contrast-Enhanced Computed Tomography—The Incidence of Contrast-Associated Acute Kidney Injury

Effect of the low-osmolality nonionic contrast media on renal function in patients undergoing coronary intervention: a prospective study

MO322: Utility of Contrast-Enhanced Ultrasound to Predict Renal Recovery in Patients With Sepsis-Associated Acute Kidney Injury Receiving Renal Replacement Therapy

Effects of Intravenous Hydration in Preventing Post-Contrast Acute Kidney Injury in Patients with Egfr < 30 Ml/min/1.73 M2.

Prevalence of Contrast-Induced Acute Kidney Injury in Acute Ischemic Stroke Patients Undergoing Contrast-Enhanced CT Angiography at a Tertiary Care Centre

Effect of IV Contrast Medium on Renal Function in Patients with Severe Acute Pancreatitis Undergoing Contrast-Enhanced CT in ICU

Impact of cardiac catheterization timing and contrast media dose on acute kidney injury after cardiac surgery

Is Intravenous Contrast Associated with Increased Risk of Acute Kidney Injury?